Coronavirus

 
Long COVID Risk Declined Over the Pandemic and Vaccination was Key, But Risk Remains
July 18, 2024

Ziyad Al-Aly, MD, and colleagues link 70% of the drop in cases to vaccine availability but caution the risk for long COVID remains significant.

Severity of SARS-CoV-2 Reinfection Similar to That of Initial Infection, According to New Findings
July 15, 2024

Researchers also found that a lower proportion of individuals were diagnosed with long COVID following reinfection than after initial infection.

Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations
July 12, 2024

Tochi Iroku-Malize, MD, discusses the ACIP's updated recommendations for immunization against COVID-19, influenza, and RSV.

States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence
July 09, 2024

A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.

CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
June 28, 2024

Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.

Defining Long COVID: Highlights from the National Academy of Sciences Consensus Report
June 17, 2024

In part the National Academies describe long COVID as "a chronic, systemic disease state with profound consequences." The report provides a working definition.

FDA Grants EUA for OTC Triple Test for COVID-19, Influenza A & B: Daily Dose
June 12, 2024

Your daily dose of the clinical news you may have missed.

Phase 3 Trial of Combination Flu/SARS-CoV-2 Vaccine Meets All Primary Endpoints: Moderna
June 11, 2024

The investigational combination vaccine elicited higher immune responses vs licensed comparator vaccines in 2 independent age groups, the company said.

FDA Grants EUA for OTC Triple Test for COVID-19, Flu A & B
June 03, 2024

The over-the-counter antigen test, for use at home or at point of care, discriminates between SARS-CoV-2 and influenza A and B in 15 minutes.